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Carnitine supplement proves to upgrade the quality of semen by increasing sperm count and 
motility. In this study we have determined the level of L – carnitine in the seminal plasma of men 
with normal and abnormal seminal analysis. L – carnitine levels among the normal group was 
significantly higher  than the abnormal group. We recommend trials of carnitine supplements to 
evaluate its usefulness in correcting some infertility cases.
Subjects and methods:
A total of 52 men, recruited from fertility centers in Khartoum, were included in this study. 
Colorimetric carnitine determination kits were used for estimation of L – carnitine in seminal 
plasma.
Results:
Collectively, men with normal values of semen analysis had significantly higher mean seminal 
plasma carnitine levels compared to abnormal values (p = 0.028). Oligospermic men had 
significantly lower levels of carnitine compared to normal (p = 0.046).
Conclusion:
Seminal plasma carnitine level seems to correlate with seminal quality and its deficiency may be a 
reason for infertility among some Sudanese men.
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-Carnitine (γ-trimethylamino-ß-
hydroxybutyrate) is synthesized in 
vivo from methionine and lysine
1
. 
Normally, the biosynthesis of L-
carnitine is sufficient to meet metabolic 
requirements, though for newborns and in 
several disease situations, oral L-carnitine 
supplements may be necessary as therapy
2
.
The primary function of L-carnitine is to act 
as a carrier for translocation of long-chain 
fatty acids from the cytosol into mitochondria 
for ß-oxidation, hence sustaining the supply 
of energy
3
.  Moreover, L-carnitine plays a 
role in other physiological processes in 
humans and animals. L-carnitine and its acyl 




oligoasthenoteratozoospermia (iOAT) is 
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Some eitiological factors include: age,
6
Chlamydia trachomatis  infection
7
, low 
seminal concentration of prostate-specific 
antigen, zinc, fructose
8
, prostatic acid 
phosphatase
9
, and low seminal activity of 
neutral alpha-glucosidase are linked to 
isolated asthenospermia as well as to 
increased viscoelasticity
10
, and osmolarity of 
seminal plasma
11
. Mitochondrial DNA 
oxidative damage has been observed in 
asthenospermic infertile men
12
. A decreased 
LH pulse frequency has been found to occur 
in iOAT men whose amplitude parallels the 
severity of the disorder
13
. Carnitine deficiency 
may also be implicated since it can enhance 
sperm motility through its positive effects on 
sperm energy production and probably 




The study was ethically approved by the 
committee of the institute of endemic 
diseases, University of Khartoum. 
Participants were recruited from Sudan 
fertility and tube baby's centre and Ashmaig 
L
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centre for tube babies, Khartoum, Sudan. A 
total of 52 males of 24 – 46 years age range 
were enrolled. With the following baseline 
sperm selection criteria: sperm concentration 
of >20 x 10
6
/mL, sperm forward motility 
>50%, and normal sperm morphology >30%, 
14 were classified as normal and 38 
abnormal. A questionnaire form including 
personal data, occupational hazards, clinical 
history, family history and previous 
achievement of pregnancy were recorded.  
Semen samples were obtained from each 
participant, after signing a consent form, by 
masturbation after 3 days or more of sexual 
abstinence. Samples were analyzed 
immediately for viscosity, sperm count, 
motility and morphology. Seminal plasma 
was obtained by centrifugation at 500 G for 5 
minutes and stored at – 20°C. For 
measurement of carnitine, seminal plasma 
was thawed and deproteinized using equal 
volume of 0.6M perchloric acid and the 
supernatant was neutralized by adding 1:4 
volumes of 1.2M potassium bicarbonate 
solution. L – carnintine was determined  using 
carnintine colorimetric kit  (Biosentic, 
Germany). Welch two sample t – test was 
used for statistical comparison. 
Results:
According to the seminal analysis results, 14 
(29.9%) were normal, 11 (21.2%) 
oligoastheno/ oligospermic, 14 (29.9%) 
asthenospermic and 13 (25%) azoospermic. 
Data of these groups are shown in table 1. 
There were no cases of teratozoospermia. 
Seven out of the 38 abnormal men (18.4%) 
were sub fertile, had achieved previous 
pregnancies with the same or another partner. 
Six of the latter were asthenospermic. Men 
with normal values of semen analysis had 
significantly higher mean seminal plasma 
carnitine levels compared to abnormal (p = 
0.022). Oligospermic men had significantly 
lower levels of carnitine compared to normal 
(p = 0.046).
Table1: Carnitine levels and other semen parameters among normal and abnormal men.
O= Oligozoospermic, As= Asthenozoospermic, Az= Azoospermic
Discussion:
Carnitine accumulates in the spermatozoa by 
passive diffusion from the epididymal 
plasma
17
. The concentration of L-carnitine in 
epididymal plasma and spermatozoa varies 
from 2 to 100 mM, which is nearly 2000-fold 
greater than circulating levels (10–50 µM). Its 
role in improving motility of sperms has been 
documented
18
. Carnitine supplements can 
modulate the Pro-inflammatory and oxidative 
stress pathways which compromise sperm 
motility and survival
19
, and may improve the 
sperm count
20
. In general, results of this study 
may indicate the importance of carnitine for 
the improvement of the quality of semen, 
especially the motility and count of sperms, 
since individuals with abnormal seminal 
analysis had significantly lower levels of 





O(N= 11) As(N=14) Az(N=13)
Previous Pregnancy 
Achievement, n (%) 
7 (50%) 7 (18.4%) 1 (9.1%) 6 (42.8%) 0 (0%)
Sperm count(millions)
(Mean±SEM)
55.1±12.1 17.9±3.2 11.5±2.0 39.5±3.9 0.0
Decreased Motility 
(<40% motile)
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individuals in this study had none 
significantly lower levels, probably due to 
small number of samples, of seminal plasma 
carnitine compared to normal. Twenty (6 sub 
fertile and 14 infertile) out of the thirty eight 
males are asthenospermic, a condition that 
proves to respond to carnitine supplements
18
.
Moreover, our results showed significantly 
lower levels of seminal plasma carnitine 
among oligospermic individuals compared to 




In conclusion, carnitine supplement seems to 
be worth trying in treatment of, at least, some 
cases of oligospermia and asthenospermia. 
Azoospermia, though associated with lower 
carnitine levels than normal, may need further 
investigation. 
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